A Phase 1b Dose EscalationStudy of Abemaciclib in Combination with Temozolomide and Irinotecan (Part A) and Abemaciclib in Combinationwith Temozolomide (Part B) in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors

Project: Research project

Project Details

Description

A Phase 1b Dose Escalation Study of Abemaciclib in Combination with Temozolomide and Irinotecan (Part A) and Abemaciclib in Combination with Temozolomide (Part B) in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors
StatusActive
Effective start/end date5/1/214/30/26

Funding

  • Eli Lilly G.m.b.H.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.